SECURITIES INFORMATION
NUMBER OF AIM SECURITIES IN ISSUE
As of 1 March 2026, the number of shares in issue was 613,362,994.
SIGNIFICANT SHAREHOLDERS
As of 1 March 2026, significant shareholdings in the share capital of Eden Research plc were:
|
Name
|
Number of shares
|
% of the issued ordinary share capital
|
|
Hargreaves Lansdown
|
62,105,689
|
10.13%
|
|
Gresham House Asset Management Limited
|
85,382,786
|
13.92%
|
|
Interactive Investor
|
41,614,549
|
6.78%
|
|
Octopus Investments
|
51,551,047
|
8.40%
|
|
Sipcam Oxon S.p.A.
|
39,285,138
|
6.40%
|
|
Canaccord Genuity Wealth Management
|
39,026,307
|
6.36%
|
|
Atul Unadkat
|
31,048,382
|
5.06%
|
|
Unicorn Asset Management
|
31,826,923
|
5.19%
|
|
J M Finn
|
21,138,202
|
3.45%
|
|
Maven Capital Partners
|
24,843,457
|
4.05%
|
|
Rathbones
|
27,465,501
|
4.48%
|
As of 1 March 2026, the directors' shareholdings in the share capital of Eden Research plc were:
|
Name
|
Number of shares
|
% of the issued ordinary share capital
|
|
A Abrey
|
3,681,678
|
0.60%
|
|
S Smith
|
3,559,768
|
0.58%
|
|
L van der Broek
|
3,482,808
|
0.57%
|
|
D McAllan
|
1,093,627
|
0.18%
|
|
R Cridland
|
745,552
|
0.12%
|
SHARES NOT IN PUBLIC HANDS
In the terms of AIM Rules published July 2016 and insofar as it is aware, at 1 March 2026, 22.37% of the Company's AIM securities was not in public hands.
RESTRICTION IN TRANSFER OF AIM SECURITIES
There are no restrictions on the transfer of Eden Research Plc's AIM securities.
DETAILS OF ANY OTHER EXCHANGES AND TRADING PLATFORMS
Eden Research Plc has not applied or agreed to have any of it securities (including its AIM securities) admitted or traded on any other exchanges or trading platforms.
UK CITY CODE ON TAKEOVERS AND MERGERS
As an AIM traded UK registered company, Eden Research plc is subject to the UK City Code on Takeovers and Mergers legislation.